Orforglipron, which could be approved for obesity next quarter, proved superior at cutting blood sugar and body weight — but at the expense of higher side effect rates.
Losing weight with the help of a prescription weight loss drug continues to increase in popularity. According to recent KFF polls, about one in eight U.S. adults takes a GLP-1 medication for ...
In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...
People who have lived with HIV long-term can need up to a dozen pills every day to suppress the virus. Results from a new ...
In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As with injectable Wegovy, most patients will start with the lowest dose and ...
Tablet Splitting: When Is It OK? Tablet splitting may not always result in weight-uniform half tablets which may result in inaccurate dosing. Tablet splitting is a common practice in the clinical ...
Trazodone is a generic prescription drug FDA-approved to treat major depressive disorder in adults. It belongs to a class of antidepressants called serotonin receptor antagonist and reuptake ...
Acimax is used to treat the symptoms of reflux oesophagitis or reflux disease. This can be caused by "washing back" (reflux) of food and acid from the stomach into the food pipe (oesophagus). Reflux ...
The approved drug is called Acetaminophen and Ibuprofen tablets, with a strength of 250 mg/125 mg, and it can be purchased over the counter (OTC). The USFDA has confirmed that this drug is equivalent ...
A pill version of blockbuster slimming drug Wegovy got the green light from US health chiefs last night, with the daily tablet expected to be launched in America in January. The approval marks the ...
This chewable tablet falls under the category of 'reflux suppressants,' which form a protective layer on top of stomach contents to prevent acid from escaping into the oesophagus, thereby alleviating ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results